Phenotype measures set:   Eumorphia2   BMC

ID, description, units MPD:25905   BMC   bone mineral content (BMC)   [g]
Measures • 12wks    • 24wks    • 52wks
Data set, strains Eumorphia2   inbred   5 strains     sex: both
Procedure DXA
Comparisonaging-study, multiple cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Eumorphia2 - bone mineral content (BMC)





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 2 0.1552 0.0776 86.4743 < 0.0001
sex 1 0.0 0.0 0.0133 0.9083
strain 2 0.5626 0.2813 313.4072 < 0.0001
age:sex 2 0.0006 0.0003 0.3469 0.7075
age:strain 4 0.0346 0.0086 9.6236 < 0.0001
sex:strain 2 0.0046 0.0023 2.5875 0.0789
age:sex:strain 4 0.0104 0.0026 2.8985 0.0243
Residuals 137 0.123 0.0009

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Eumorphia2 25905 DXA (none) bone mineral content (BMC)   [g]   at age 12wks   BMC_12wk inbred 5 both
Eumorphia2 25915 DXA (none) bone mineral content (BMC)   [g]   at age 24wks   BMC_24wk inbred 4 both
Eumorphia2 25925 DXA (none) bone mineral content (BMC)   [g]   at age 52wks   BMC_52wk inbred 4 both